Charité University Medicine
Berlin, 10117, Germany
NCT Number: NCT01399073
Compared to the classical "paper and pencil"-tests, testing patients in our virtual reality setup might have a higher sensitivity and specificity.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Observational
Berlin, 10117, Germany
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
for neglect patients:
Inclusion criteria
for hemianopsia patients:
Inclusion criteria
for Controls:
Exclusion criteria
(for all groups):
testing for neglect in a virtual reality setup
testing for neglect with the classical paper-and-pencil tests
structural and functional (resting state) imaging
Time frame: within the first 2 years after stroke
Feasibility of the use of a virtual reality setup in the diagnostics of neglect
Time frame: within the first 2 years after stroke
The diagnostics of neglect via a virtual reality setup is more sensitive and more specific than the standard diagnostics via "paper-and-pencil" Tests
Time frame: within the first 2 years after stroke
We hypothesize that there are connectivity-based differences in the different stages of neglect and anatomical and functional connectivity correlates with respect to behavioural impairment.
Charite University, Berlin, Germany
Other
Acronym: KMS-Neglect
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07507383
Brain Diseases, Cardiovascular Diseases
Ankara, Turkey (Türkiye)
View Trial DetailsNCT04387162
Aphasia, Brain Diseases
Decatur, Georgia, United States
View Trial DetailsNCT05060458
Brain Diseases, Cardiovascular Diseases
Edegem, Belgium
View Trial DetailsNCT03349411
Brain Diseases, Cardiovascular Diseases
West Orange, New Jersey, United States
View Trial Details